Swiss National Bank - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 115 filers reported holding MIRATI THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.7%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,870,008
+52.1%
111,800
+26.2%
0.00%
+100.0%
Q2 2023$3,201,118
-1.0%
88,600
+1.8%
0.00%0.0%
Q1 2023$3,234,660
-24.1%
87,000
-7.4%
0.00%
-33.3%
Q4 2022$4,259,140
-33.9%
94,000
+2.0%
0.00%
-40.0%
Q3 2022$6,439,000
+5.1%
92,200
+1.0%
0.01%
+25.0%
Q2 2022$6,129,000
-18.4%
91,3000.0%0.00%0.0%
Q1 2022$7,507,000
-35.6%
91,300
+14.8%
0.00%
-42.9%
Q4 2021$11,662,000
-17.2%
79,500
-0.1%
0.01%
-22.2%
Q3 2021$14,082,000
+11.6%
79,600
+1.9%
0.01%
+12.5%
Q2 2021$12,615,000
-8.4%
78,100
-2.9%
0.01%
-11.1%
Q1 2021$13,773,000
-4.3%
80,400
+22.7%
0.01%
-10.0%
Q4 2020$14,386,000
+34.7%
65,500
+1.9%
0.01%
+25.0%
Q3 2020$10,677,000
+48.2%
64,300
+1.9%
0.01%
+33.3%
Q2 2020$7,204,000
+88.6%
63,100
+27.0%
0.01%
+50.0%
Q1 2020$3,820,000
-39.4%
49,700
+1.6%
0.00%
-33.3%
Q4 2019$6,301,000
+84.2%
48,900
+11.4%
0.01%
+50.0%
Q3 2019$3,420,000
-22.2%
43,900
+2.8%
0.00%
-20.0%
Q2 2019$4,398,000
+68.6%
42,700
+19.9%
0.01%
+66.7%
Q1 2019$2,609,000
+79.3%
35,600
+3.8%
0.00%
+50.0%
Q4 2018$1,455,000
+2.0%
34,300
+13.2%
0.00%0.0%
Q3 2018$1,427,000
-4.5%
30,3000.0%0.00%0.0%
Q2 2018$1,494,000
+974.8%
30,300
+44.3%
0.00%
Q3 2016$139,000
+20.9%
21,0000.0%0.00%
Q2 2016$115,000
-73.5%
21,0000.0%0.00%
-100.0%
Q1 2016$434,000
-14.7%
21,000
+30.4%
0.00%0.0%
Q4 2015$509,000
-8.1%
16,1000.0%0.00%0.0%
Q3 2015$554,000
+104.4%
16,100
+87.2%
0.00%0.0%
Q2 2015$271,0008,6000.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders